Nasdaq moves to remove Jasper Therapeutics warrants

The warrant terms specify ten warrants for one share of Voting Common Stock at a $115.00 exercise price.

Rhea-AI Filing Summary

Jasper Therapeutics, Inc. is the issuer of redeemable warrants named in Nasdaq Stock Market LLC’s notification of removal from listing and/or registration. Nasdaq stated that it complied with its rules to strike the warrant class from listing and/or withdraw its registration. The warrants are exercisable in groups of ten for one share of Voting Common Stock at an exercise price of $115.00.

Filing Explained

The notice says Jasper met requirements for voluntary withdrawal of its warrant class, alongside Nasdaq’s statement that it complied with rules to remove that class from listing and/or registration.

Key Figures

Warrant exercise ratio: 10 warrants per 1 share of Voting Common Stock Exercise price: $115.00

2 metrics

Warrant exercise ratio 10 warrants per 1 share of Voting Common Stock Redeemable warrant terms

Exercise price $115.00 Redeemable warrant terms

Key Terms

Redeemable Warrants, exercise price, Section 12(b)

3 terms

Redeemable Warrants financial

"Redeemable Warrants, each ten warrants exercisable for one share"

A redeemable warrant is a tradable right that lets its holder buy a company’s shares at a fixed price before a set date, but the issuer has the contract power to cancel (redeem) the warrant early under agreed terms. For investors this matters because early redemption can force decision-making, change the timing of when new shares might be created, and affect potential gains or dilution—much like a store coupon that the issuer can cancel by paying you off instead of letting you use it.

exercise price financial

"at an exercise price of $115.00"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Section 12(b) regulatory

"under Section 12(b) of the Securities Exchange Act of 1934"

Section 12(b) of the U.S. Securities Exchange Act requires securities listed on a national stock exchange to be registered with the U.S. Securities and Exchange Commission (SEC) and to follow regular public reporting and disclosure rules. For investors, a 12(b) listing generally means more routine financial updates, regulatory oversight and easier buying and selling—like a storefront that must display its inventory and prices, making it simpler to inspect and trade the product.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What Jasper Therapeutics securities does Nasdaq’s Form 25 notice cover?

Nasdaq’s notice identifies Jasper Therapeutics’ redeemable warrants for removal from listing and/or registration. The warrants are exercisable in groups of ten for one share of Voting Common Stock at an exercise price of $115.00.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/24/2026 - 04:16 PM Accepted by SEC EDGAR 09/24/2026 - 04:15 PM Learn about SEC filing dates

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-39138

Issuer:	Jasper Therapeutics, Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	2200 Bridge Pkwy
	Suite #102
	Redwood City	CALIFORNIA	94065
Telephone number:					(650) 549-1400

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Redeemable Warrants, each ten warrants exercisable for one share of Voting Common Stock at an exercise price of $115.00

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-09-24	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.